Vaxart (VXRT) Research & Development (2010 - 2026)
Vaxart (VXRT) reported Research & Development of $33.75 million for Q2 2026, down 32.1% from $49.74 million a year earlier but up 14.8% from the prior quarter.
Powered by 
Analysis
Vaxart (VXRT) Research & Development (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vaxart's Research & Development came in at $184.26 million, up 55.9% year-over-year; for FY2025, it came in at $201.58 million, up 171.6% from FY2024.
- Research & Development has a five-year compound annual growth rate of 59.0% (FY2020 to FY2025).
- By year, Research & Development came in at $74.21 million in FY2024 (+8.9%), $68.14 million in FY2023 (-15.9%), $81.05 million in FY2022 (+66.3%) and $48.75 million in FY2021 (+145.4%).
- Five-year quarterly Research & Development spans a low of $12.41 million in Q3 2021 and a high of $75.95 million in Q3 2025.
- Year over year, Research & Development gained in six of the last eight quarters, with growth averaging 96.0%.
- The high point for year-over-year Research & Development in five years was Q3 2025 (growth of 404.1%); the low point was Q3 2023 (a decline of 33.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $29.41 million (Q1 2026), $45.15 million (Q4 2025) and $75.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,157.52 Bn | 1,126.11 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 631.39 Bn | 549.92 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 498.93 Bn | 472.04 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 376.05 Bn | 330.42 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 301.98 Bn | 265.97 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 265.05 Bn | 238.74 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 240.27 Bn | 195.67 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 193.08 Bn | 167.27 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.85 Bn | 118.50 Bn | 10.94 Bn | 2.81 Bn |
| 10 | Vaxart | 116.24 Mn | 52.24 Mn | - | 33.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 33.75 Mn |
| Mar 31, 2026 | 29.41 Mn |
| Dec 31, 2025 | 45.15 Mn |
| Sep 30, 2025 | 75.95 Mn |
| Jun 30, 2025 | 49.74 Mn |
| Mar 31, 2025 | 30.74 Mn |
| Dec 31, 2024 | 22.65 Mn |
| Sep 30, 2024 | 15.07 Mn |
| Jun 30, 2024 | 17.48 Mn |
| Mar 31, 2024 | 19.01 Mn |
| Dec 31, 2023 | 14.71 Mn |
| Sep 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 18.81 Mn |
| Mar 31, 2023 | 19.62 Mn |
| Dec 31, 2022 | 20.46 Mn |
| Sep 30, 2022 | 22.47 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 18.20 Mn |
| Dec 31, 2021 | 15.53 Mn |
| Sep 30, 2021 | 12.41 Mn |
API Access
Vaxart Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=VXRT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "VXRT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=VXRT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();